肌球蛋白重链基因在人类遗传性疾病中的研究进展

doi:10.16288/j.yczz.17-090

遗传 ›› 2017, Vol. 39 ›› Issue (10): 877-887.doi: 10.16288/j.yczz.17-090

肌球蛋白重链基因在人类遗传性疾病中的研究进展

何一旻(),顾鸣敏()

上海交通大学医学院医学遗传学实验室,上海 200025

收稿日期:2017-03-16 修回日期:2017-07-25 出版日期:2017-10-20 发布日期:2017-08-07
作者简介:何一旻,硕士研究生,专业方向：遗传病的基因定位和功能研究。E-mail: hq2008@sjtu.edu.cn|顾鸣敏，教授，研究方向：遗传病的基因定位和功能研究。E-mail: gumm@sjtu.edu.cn
基金资助:
国家自然科学基金项目(31571295)

Research progress of myosin heavy chain genes in human genetic diseases

He Yimin(),Gu Mingmin()

Medical Genetics Lab, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received:2017-03-16 Revised:2017-07-25 Online:2017-10-20 Published:2017-08-07
Supported by:
the National Natural Science Foundation of China(31571295)

摘要/Abstract

摘要：

肌球蛋白超家族通过水解ATP,将化学能转化为机械能,在细胞迁移、肌肉收缩等多种生理活动中发挥重要的作用。其中,肌球蛋白Ⅱ类分子是肌细胞和非肌细胞中肌丝的重要组成成分。一个完整的肌球蛋白Ⅱ类分子是由2条肌球蛋白重链(myosin heavy chain, MyHC)和2对不同的轻链组成的六聚体。在人体中,存在多种MyHC亚型,分别由不同的MYH基因家族成员编码。迄今为止,人们已经发现MYH基因家族中多个成员的不同突变与人类遗传性疾病相关。其中,MYH2突变可以导致一类以眼肌麻痹为主要特征的骨骼肌疾病;MYH3和MYH8突变可以引起远端关节挛缩综合征;MYH7突变即可以引起骨骼肌疾病包括肌球蛋白沉积性肌病和Laing远端肌病,也与肥厚性心肌病的发生密切相关;MYH9突变可以导致一类以巨大血小板、血小板减少和中性粒细胞包涵体为特征的MYH9相关性疾病。本文简要介绍MYH基因的表达特点,着重阐述MYH基因与人类遗传性疾病之间的相关性及研究进展。

关键词: MYH基因家族, 肌球蛋白重链, 遗传性疾病

Abstract:

Myosins constitute a large superfamily proteins, which convert chemical energy, through ATP hydrolysis, to mechanical force for diverse cellular movements, such as cell migration and muscle contraction. The class Ⅱ myosin forms the filaments in muscle and non-muscle cells as a hexameric protein complex, consisting of two myosin heavy chain (MyHC) subunits and two pairs of non-identical light chain subunits. There are several MyHC isoforms encoded by different genes of the MYH family in humans. At present, distinct mutations in different genes of the MYH family are associated with various human genetic diseases. Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia. Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes. Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy. Mutations in MYH9 are associated with the so-called MYH9-related disease, characterized by giant platelets, thrombocytopenia and granulocyte inclusions. In this review, we briefly discuss the expression patterns of the MYH gene family and summarize the research progress in correlating the abnormalities of MYH gene family with various human genetic diseases.

Key words: MYH gene family, myosin heavy chain, genetic diseases

何一旻, 顾鸣敏. 肌球蛋白重链基因在人类遗传性疾病中的研究进展[J]. 遗传, 2017, 39(10): 877-887.

He Yimin, Gu Mingmin. Research progress of myosin heavy chain genes in human genetic diseases[J]. Hereditas(Beijing), 2017, 39(10): 877-887.

参考文献

[1]	Foth BJ, Goedecke MC, Soldati D. New insights into myosin evolution and classification. Proc Natl Acad Sci USA, 2006, 103(10): 3681-3686.
[2]	Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta, 2000, 1496(1): 3-22.
[3]	Clark KA, McElhinny AS, Beckerle MC, Gregorio CC. Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol, 2002, 18: 637-706.
[4]	Willis T, Hedberg-Oldfors C, Alhaswani Z, Kulshrestha R, Sewry C, Oldfors A. A novel.MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness. J Neurol, 2016, 263(7): 1427-1433.
[5]	Colegrave M, Peckham M. Structural implications of β-cardiac myosin heavy chain mutations in human disease. Anat Rec (Hoboken), 2014, 297(9): 1670-1680.
[6]	Eichel Y, Tormos LM, Squires JE. Preoperative use of platelets in a 6-year-old with acute appendicitis and a myosin heavy chain 9-related disorder: a case report and review of literature. Transfusion, 2016, 56(2): 349-353.
[7]	Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev, 2011, 91(4): 1447-1531.
[8]	Pedrosa-Domell?f F, Holmgren Y, Lucas CA, Hoh JFY, Thornell LE. Human extraocular muscles: unique pattern of myosin heavy chain expression during myotube formation. Invest Ophthalmol Vis Sci, 2000, 41(7): 1608-1616.
[9]	Oldfors A. Hereditary myosin myopathies. Neuromuscul Disord, 2007, 17(5): 355-367.
[10]	Newell-Litwa KA, Horwitz R, Lamers ML. Non-muscle myosin II in disease: mechanisms and therapeutic opportunities. Dis Model Mech, 2015, 8(12): 1495-1515.
[11]	Toydemir RM, Rutherford A, Whitby FG, Jorde LB, Carey JC, Bamshad MJ. Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat Genet, 2006, 38(5): 561-565.
[12]	Chong JX, Burrage LC, Beck AE, Marvin CT, McMillin MJ, Shively KM, Harrell TM, Buckingham KJ, Bacino CA, Jain M, Alanay Y, Berry SA, Carey JC, Gibbs RA, Lee BH, Krakow D, Shendure J, Nickerson DA, University of Washington Center for Mendelian Genomics, Bamshad MJ. Autosomal-dominant multiple pterygium syndrome is caused by mutations in MYH3. Am J Hum Genet, 2015, 96(5): 841-849.
[13]	Posch MG, Waldmuller S, Müller M, Scheffold T, Fournier D, Andrade-Navarro MA, De Geeter B, Guillaumont S, Dauphin C, Yousseff D, Schmitt KR, Perrot A, Berger F, Hetzer R, Bouvagnet P, ?zcelik C. Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One, 2011, 6(12): e28872.
[14]	Ishikawa T, Jou CJ, Nogami A, Kowase S, Arrington CB, Barnett SM, Harrell DT, Arimura T, Tsuji Y, Kimura A, Makita N. Novel mutation in the α-myosin heavy chain gene is associated with sick sinus syndrome. Circ Arrhythm Electrophysiol, 2015, 8(2): 400-408.
[15]	Carniel E, Taylor MRG, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, Bristow MR, Mestroni L. α-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation, 2005, 112(1): 54-59.
[16]	Walsh R, Rutland C, Thomas R, Loughna S. Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations. Cardiology, 2010, 115(1): 49-60.
[17]	Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hurlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation, 2008, 117(22): 2893-2901.
[18]	Lamont PJ, Wallefeld W, Hilton-Jones D, Udd B, Argov Z, Barboi AC, Bonneman C, Boycott KM, Bushby K, Connolly AM, Davies N, Beggs AH, Cox GF, Dastgir J, DeChene ET, Gooding R, Jungbluth H, Muelas N, Palmio J, Penttil? S, Schmedding E, Suominen T, Straub V, Staples C, Van Den Bergh PYK, Vilchez JJ, Wagner KR, Wheeler PG, Wraige E, Laing NG. Novel mutations widen the phenotypic spectrum of slow skeletal/β-cardiac myosin (MYH7) distal myopathy. Hum Mutat, 2014, 35(7): 868-879.
[19]	Pegoraro E, Gavassini BF, Borsato C, Melacini P, Vianello A, Stramare R, Cenacchi G, Angelini C. MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord, 2007, 17(4): 321-329.
[20]	Yüceyar N, Ayhan ?, Karasoy H, Tolun A. Homozygous MYH7 R1820W mutation results in recessive myosin storage myopathy: scapuloperoneal and respiratory weakness with dilated cardiomyopathy. Neuromuscul Disord, 2015, 25(4): 340-344.
[21]	Bonapace G, Ceravolo F, Piccirillo A, Duro G, Strisciuglio P, Concolino D. Germline mosaicism for the c.2021G > A (p.Arg674Gln) mutation in siblings with trismus pseudocamptodactyly. Am J Med Genet A, 2010, 152A(11): 2898-2900.
[22]	Kunishima S, Saito H. Advances in the understanding of MYH9 disorders. Curr Opin Hematol, 2010, 17(5): 405-410.
[23]	Hildebrand MS, De Silva MG, Gardner RJM, Rose E, De Graaf CA, Bahlo M, Dahl HHM. Cochlear implants for DFNA17 deafness. Laryngoscope, 2006, 116(12): 2211-2215.
[24]	Kunishima S, Matsushita T, Shiratsuchi M, Ikuta T, Nishimura J, Hamaguchi M, Naoe T, Saito H. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness. Eur J Haematol, 2005, 74(1): 1-5.
[25]	Zhu LM, Vranckx R, Van Kien PK, Lalande A, Boisset N, Mathieu F, Wegman M, Glancy L, Gasc JM, Brunotte F, Bruneval P, Wolf JE, Michel JB, Jeunemaitre X. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet, 2006, 38(3): 343-349.
[26]	Yang R, Li H, Zhan CX, Mao HY, Zhan TL, Zhu ZF, Liu P, Yuan WL, Ke T, Wang Q, Liu MG, Tang ZH. c. 359T>C mutation of the MYH14 gene in two autosomal dominant non-syndromic hearing impairment families with common ancestor. Chin J Med Genet, 2010, 27(3): 259-262.
[26]	杨嵘, 李浒, 詹成雄, 冒海燕, 詹泰岚, 朱正烽, 刘平, 袁文林, 柯铁, 王擎, 刘木根, 唐朝晖. 两个有血缘关系的常染色体显性非综合性耳聋家系基因突变分析. 中华医学遗传学杂志, 2010, 27(3): 259-262.
[27]	Choi BO, Kang SH, Hyun YS, Kanwal S, Park SW, Koo H, Kim SB, Choi YC, Yoo JH, Kim JW, Park KD, Choi KG, Kim SJ, Züchner S, Chung KW. A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in. MYH14. Hum Mutat, 2011, 32(6): 669-677.
[28]	Martinsson T, Oldfors A, Darin N, Berg K, Tajsharghi H, Kyllerman M, Wahlstrom J. Autosomal dominant myopathy: missense mutation (Glu-706→Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci USA, 2000, 97(26): 14614-14619.
[29]	Tajsharghi H, Oldfors A. Myosinopathies: pathology and mechanisms. Acta Neuropathol, 2013, 125(1): 3-18.
[30]	D'Amico A, Fattori F, Bellacchio E, Catteruccia M, Servidei S, Bertini E. A new de novo missense mutation in. MYH2 expands clinical and genetic findings in hereditary myosin myopathies. Neuromuscul Disord, 2013, 23(5): 437-440.
[31]	Cabrera-Serrano M, Fabian VA, Boutilier J, Wise C, Faiz F, Lamont PJ, Laing NG. Adult onset distal and proximal myopathy with complete ophthalmoplegia associated with a novel. de novo p.( Leu1877Pro) mutation in MYH2. Clin Genet, 2015, 88(6): 573-578.
[32]	Guo WT, Xu WY, Gu MM. Nonsense-mediated mRNA decay and human monogenic disease. Hereditas (Beijing), 2012, 34(8): 935-942.
[32]	郭文婷, 徐汪洋, 顾鸣敏. 无义介导的mRNA降解机制及其在单基因遗传病中的作用. 遗传, 2012, 34(8): 935-942.
[33]	Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B. Human disease caused by loss of fast IIa myosin heavy chain due to recessive. MYH2 mutations. Brain, 2010, 133(Pt 5): 1451-1459.
[34]	Tajsharghi H, Hammans S, Lindberg C, Lossos A, Clarke NF, Mazanti I, Waddell LB, Fellig Y, Foulds N, Katifi H, Webster R, Raheem O, Udd B, Argov Z, Oldfors A. Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations. Eur J Hum Genet, 2014, 22(6): 801-808.
[35]	Bamshad M, Jorde LB, Carey JC. A revised and extended classification of the distal arthrogryposes. Am J Med Genet, 1996, 65(4): 277-281.
[36]	Kimber E, Tajsharghi H, Kroksmark AK, Oldfors A, Tulinius M. A mutation in the fast skeletal muscle troponin I gene causes myopathy and distal arthrogryposis. Neurology, 2006, 67(4): 597-601.
[37]	Tajsharghi H, Ohlsson M, Palm L, Oldfors A. Myopathies associated with β-tropomyosin mutations. Neuromuscul Disord, 2012, 22(11): 923-933.
[38]	Walklate J, Vera C, Bloemink MJ, Geeves MA, Leinwand L. The most prevalent freeman-sheldon syndrome mutations in the embryonic myosin motor share functional defects. J Biol Chem, 2016, 291(19): 10318-10331.
[39]	Racca AW, Beck AE, McMillin MJ, Korte FS, Bamshad MJ, Regnier M. The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle. Hum Mol Genet, 2015, 24(12): 3348-3358.
[40]	Tajsharghi H, Oldfors A, Macleod DP, Swash M. Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy. Neurology, 2007, 68(12): 962.
[41]	Armel TZ, Leinwand LA. Mutations in the β-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci USA, 2009, 106(15): 6291-6296.
[42]	Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, Pedemonte M, Trovato R, Ruggiero L, Vercelli L, D'Amico A, Tasca G, Pane M, Fanin M, Bello L, Broda P, Musumeci O, Rodolico C, Messina S, Vita GL, Sframeli M, Gibertini S, Morandi L, Mora M, Maggi L, Petrucci A, Massa R, Grandis M, Toscano A, Pegoraro E, Mercuri E, Bertini E, Mongini T, Santoro L, Nigro V, Minetti C, Santorelli FM, Bruno C. MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet J Rare Dis, 2016, 11(1): 91-104.
[43]	Buvoli M, Buvoli A, Leinwand LA. Effects of pathogenic proline mutations on myosin assembly. J Mol Biol, 2012, 415(5): 807-818.
[44]	Feinstein-Linial M, Buvoli M, Buvoli A, Sadeh M, Dabby R, Straussberg R, Shelef I, Dayan D, Leinwand LA, Birk OS. Two novel MYH7 proline substitutions cause Laing Distal Myopathy-like phenotypes with variable expressivity and neck extensor contracture. BMC Med Genet, 2016, 17(1): 57-65.
[45]	Cao H, Zhao Y, Feng Y, Zhang H, Xia XS. Advances in researches on MYH7 gene mutations in Chinese patients with hypertrophic cardiomyopathy. J Med Mol Biol, 2016, 13(1): 27-34.
[45]	曹红, 赵跃, 冯悦, 张宏, 夏雪山. 中国人群肥厚型心肌病MYH7基因突变的研究与展望. 医学分子生物学杂志, 2016, 13(1): 27-34.
[46]	Moore JR, Leinwand L, Warshaw DM. Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circ Res, 2012, 111(3): 375-385.
[47]	Seebohm B, Matinmehr F, K?hler J, Francino A, Navarro-Lopéz F, Perrot A, ?zcelik C, McKenna WJ, Brenner B, Kraft T. Cardiomyopathy mutations reveal variable region of myosin converter as major element of cross-bridge compliance. Biophys J, 2009, 97(3): 806-824.
[48]	Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang LB, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE, Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest, 2010, 120(10): 3520-3529.
[49]	Witjas-Paalberends ER, Ferrara C, Scellini B, Piroddi N, Montag J, Tesi C, Stienen GJM, Michels M, Ho CY, Kraft T, Poggesi C, Van Der Velden J. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation. J Physiol, 2014, 592(15): 3257-3272.
[50]	Balduini CL, Savoia A, Seri M. Inherited thrombocytopenias frequently diagnosed in adults. J Thromb Haemost, 2013, 11(6): 1006-1019.
[51]	Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, Gresele P, Lethagen S, Fabris F, Dufour C, Granata A, Doubek M, Pecoraro C, Koivisto PA, Heller PG, Iolascon A, Alvisi P, Schwabe D, De Candia E, Rocca B, Russo U, Ramenghi U, Noris P, Seri M, Balduini CL, Savoia A. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat, 2008, 29(3): 409-417.
[52]	Verver EJJ, Topsakal V, Kunst HPM, Huygen PLM, Heller PG, Pujol-Moix N, Savoia A, Benazzo M, Fierro T, Grolman W, Gresele P, Pecci A. nonmuscle myosin heavy chain IIA mutation predicts severity and progression of sensorineural hearing loss in patients with MYH9-related disease. EAR Hear, 2016, 37(1): 112-120.
[53]	Pecci A, Klersy C, Gresele P, Lee KJD, De Rocco D, Bozzi V, Russo G, Heller PG, Loffredo G, Ballmaier M, Fabris F, Beggiato E, Kahr WHA, Pujol-Moix N, Platokouki H, Van Geet C, Noris P, Yerram P, Hermans C, Gerber B, Economou M, De Groot M, Zieger B, De Candia E, Fraticelli V, Kersseboom R, Piccoli GB, Zimmermann S, Fierro T, Glembotsky AC, Vianello F, Zaninetti C, Nicchia E, Gütthner C, Baronci C, Seri M, Knight PJ, Balduini CL, Savoia A. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat, 2014, 35(2): 236-247.
[54]	Liu HY, Li T, Wang HD, Guo LJ, Wu D, Xiao H, Guo QN, Wang T. Mutation analysis for a large Chinese family affected with MYH9-related thrombocytopenia. Chin J Med Genet, 2016, 33(5): 629-632.
[54]	刘红彦, 李涛, 王红丹, 郭梁洁, 吴东, 肖海, 郭谦楠, 王涛. 一个MYH9基因相关性血小板减少症家系的基因突变分析. 中华医学遗传学杂志, 2016, 33(5): 629-632.
[55]	Matsushita T, Hayashi H, Kunishima S, Hayashi M, Ikejiri M, Takeshita K, Yuzawa Y, Adachi T, Hirashima K, Sone M, Yamamoto K, Takagi A, Katsumi A, Kawai K, Nezu T, Takahashi M, Nakashima T, Naoe T, Kojima T, Saito H. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Biochem Biophys Res Commun, 2004, 325(4): 1163-1171.
[56]	Zhang YF, Conti MA, Malide D, Dong F, Wang AB, Shmist YA, Liu CY, Zerfas P, Daniels MP, Chan CC, Kozin E, Kachar B, Kelley MJ, Kopp JB, Adelstein RS. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood, 2012, 119(1): 238-250.
[57]	Chen Z, Naveiras O, Balduini A, Mammoto A, Conti MA, Adelstein RS, Ingber D, Daley GQ, Shivdasani RA. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood, 2007, 110(1): 171-179.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

肌球蛋白重链基因在人类遗传性疾病中的研究进展

Research progress of myosin heavy chain genes in human genetic diseases

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

[1]	袁慧军, 卢宇. 新一代测序技术在遗传性耳聋基因研究及诊断中的应用[J]. 遗传, 2014, 36(11): 1112-1120.
[2]	邵谦之, 姜毅, 吴金雨. 全基因组测序及其在遗传性疾病研究及诊断中的应用[J]. 遗传, 2014, 36(11): 1087-1098.
[3]	王虎，邹玉宝，宋雷，王继征，孙凯，宋晓东，高硕，张禅那，惠汝太. 心脏肌球蛋白重链基因c.1273G>A突变与肥厚型心肌病的关联分析[J]. 遗传, 2009, 31(5): 485-488.
[4]	颜志强，杨胜利，龚毅. PCR及其衍生技术在基因突变检测中的应用[J]. 遗传, 2003, 25(2): 198-200.
[5]	夏峰，曹勇军，洪宗元，李美英，丁绍青. 一个罕见的屈指畸形家系的遗传学调查 [J]. 遗传, 2002, 24(6): 646-648.